1. Home
  2. TLX

TLX

Telix Pharmaceuticals Limited American Depositary Shares

as 12-06-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 2015 Country:
Australia
Australia
Employees: N/A City: N/A
Market Cap: 5.0B IPO Year: N/A
Target Price: $21.00 AVG Volume (30 days): 24.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.10 EPS Growth: N/A
52 Week Low/High: $14.44 - $19.99 Next Earning Date: 01-01-0001
Revenue: $430,795,970 Revenue Growth: 80.92%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest Telix Pharmaceuticals Limited American Depositary Shares News

TLX Breaking Stock News: Dive into TLX Ticker-Specific Updates for Smart Investing

All TLX News

Share on Social Networks: